Temozolomide NDC 47335-930

NDC codes

FDA NDC Directory

Product NDC (as listed)47335-930Labeler and product segments. Claims need a package NDC.

Product NDC at billing width47335-0930Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
47335-930-21	47335093021	1 BOTTLE in 1 CARTON (47335-930-21) / 14 CAPSULE in 1 BOTTLEMarketed from Feb 13, 2014
47335-930-72	47335093072	15 BLISTER PACK in 1 CARTON (47335-930-72) / 1 CAPSULE in 1 BLISTER PACKMarketed from Feb 13, 2014
47335-930-74	47335093074	5 BLISTER PACK in 1 CARTON (47335-930-74) / 1 CAPSULE in 1 BLISTER PACKMarketed from Feb 13, 2014
47335-930-75	47335093075	20 BLISTER PACK in 1 CARTON (47335-930-75) / 1 CAPSULE in 1 BLISTER PACKMarketed from Feb 13, 2014
47335-930-80	47335093080	1 BOTTLE in 1 CARTON (47335-930-80) / 5 CAPSULE in 1 BOTTLEMarketed from Feb 13, 2014
47335-930-87	47335093087	1 BOTTLE in 1 CARTON (47335-930-87) / 20 CAPSULE in 1 BOTTLEMarketed from Feb 13, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Temozolomide
Generic name (nonproprietary): temozolomide
Active ingredients: Temozolomide — 180 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Sun Pharmaceutical Industries, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201742
Marketing start: Feb 13, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Alkylating Activity (Mechanism)
Identifiers: Product ID 47335-930_7c774570-443b-40da-8038-7cb550f92048SPL ID 7c774570-443b-40da-8038-7cb550f92048SPL set ID c1e05c21-a411-4493-80de-ede373632475RxCUI 313209, 313210, 313211, 317160, 700883, 700885UNII YF1K15M17Y
Pharmacologic class: Alkylating Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N447335093021 followed by a unit qualifier and the quantity

Package 47335-0930-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 14, 2025.

Indications (excerpt from the label)

Temozolomide is an alkylating drug indicated for the treatment of adults with: • Newly diagnosed glioblastoma concomitantly with radiotherapy and then as maintenance treatment. (1.1) • Anaplastic astrocytoma. (1.2) o Adjuvant treatment of adults with newly diagnosed anaplastic astrocytoma. (1.2) o Treatment of adults with refractory anaplastic astrocytoma. (1.2) 1.1 Newly Diagnosed Glioblastoma Temozolomide capsules are indicated for the treatment of adults with newly diagnosed glioblastoma, concomitantly with radiotherapy and then as maintenance treatment. 1.2 Anaplastic Astrocytoma Temozolomide capsules are indicated for the: • adjuvant treatment of adults with newly diagnosed anaplastic a…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 201742

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201742
Product	Strength	Form · route	Labeler	Product NDC
Temozolomide	Temozolomide 250 mg/1	CapsuleOral	Sun Pharmaceutical Industries, Inc.	47335-893
Temozolomide	Temozolomide 5 mg/1	CapsuleOral	Sun Pharmaceutical Industries, Inc.	47335-890
Temozolomide	Temozolomide 20 mg/1	CapsuleOral	Sun Pharmaceutical Industries, Inc.	47335-891
Temozolomide	Temozolomide 100 mg/1	CapsuleOral	Sun Pharmaceutical Industries, Inc.	47335-892
Temozolomide	Temozolomide 140 mg/1	CapsuleOral	Sun Pharmaceutical Industries, Inc.	47335-929